These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39158637)

  • 1. ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG).
    Stoop TF; Augustinus S; Andersson B; Ghorbani P; Wellner UF; Uhl W; Besselink MG; Pitt HA; Del Chiaro M;
    Ann Surg Oncol; 2024 Nov; 31(12):8354-8355. PubMed ID: 39158637
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG).
    Stoop TF; Augustinus S; Björnsson B; Tingstedt B; Andersson B; Wolfgang CL; Werner J; Johansen K; Stommel MWJ; Katz MHG; Ghadimi M; House MG; Ghorbani P; Molenaar IQ; de Wilde RF; Mieog JSD; Keck T; Wellner UF; Uhl W; Besselink MG; Pitt HA; Del Chiaro M;
    Ann Surg Oncol; 2024 Nov; 31(12):8327-8339. PubMed ID: 39120839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASO Visual Abstract: Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma : A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG).
    Stoop TF; Augustinus S; Björnsson B; Tingstedt B; Andersson B; Wolfgang CL; Werner J; Johansen K; Stommel MWJ; Katz MHG; Ghadimi M; House MG; Ghorbani P; Molenaar IQ; de Wilde RF; Mieog JSD; Keck T; Wellner UF; Uhl W; Besselink MG; Pitt HA; Del Chiaro M;
    Ann Surg Oncol; 2024 Oct; ():. PubMed ID: 39402315
    [No Abstract]   [Full Text] [Related]  

  • 4. International differences in the selection and outcome of minimally invasive and open distal pancreatectomy: A transatlantic analysis.
    Johansen KU; Augustinus S; Wellner UF; Andersson B; Beane JD; Björnsson B; Busch OR; Davis CH; Ghadimi M; Gleeson EM; de Graaf N; Koerkamp BG; Pitt HA; van Santvoort HC; Tingstedt B; Uhl W; Werner J; Williamsson C; Besselink MG; Keck T;
    Surgery; 2024 Oct; 176(4):1198-1206. PubMed ID: 39019733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal vein resection in pancreatic head carcinoma. Part 1: Technical considerations.
    Tuech JJ; Pessaux P; Arnaud JP
    Hepatogastroenterology; 2001; 48(39):884-7. PubMed ID: 11462948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients.
    Ramacciato G; Nigri G; Petrucciani N; Pinna AD; Ravaioli M; Jovine E; Minni F; Grazi GL; Chirletti P; Tisone G; Napoli N; Boggi U
    Ann Surg Oncol; 2016 Jun; 23(6):2028-37. PubMed ID: 26893222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is pancreatectomy with resection of the retro-pancreatic vessels for cancer justified?].
    Baulieux J; Adham M; Oussoultzoglou E; De la Roche E; Berthoux N; Bourdeix O; Ducerf C
    Chirurgie; 1998 Nov; 123(5):438-44. PubMed ID: 9882911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
    Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
    Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
    Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection.
    Prakash LR; Wang H; Zhao J; Nogueras-Gonzalez GM; Cloyd JM; Tzeng CD; Kim MP; Lee JE; Katz MHG
    J Gastrointest Surg; 2020 Feb; 24(2):368-379. PubMed ID: 30820801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining venous involvement in borderline resectable pancreatic cancer.
    Chun YS; Milestone BN; Watson JC; Cohen SJ; Burtness B; Engstrom PF; Haluszka O; Tokar JL; Hall MJ; Denlinger CS; Astsaturov I; Hoffman JP
    Ann Surg Oncol; 2010 Nov; 17(11):2832-8. PubMed ID: 20725860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a pancreatectomy with a limited venous resection for pancreatic cancer.
    Illuminati G; Carboni F; Lorusso R; D'Urso A; Ceccanei G; Papaspyropoulos V; Pacile MA; Santoro E
    Surg Today; 2008; 38(6):517-23. PubMed ID: 18516531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pancreatic carcinoma presenting with invasion of the vena porta or the superior mesenteric vein: our experience and review of the literature].
    Ramacciato G; Mercantini P; Petrucciani N; Romano C; Nigri G; Aurello P; D'Angelo F; Ravaioli M; Del Gaudio M; Cucchetti A; Ercolani G
    Minerva Chir; 2010 Dec; 65(6):587-99. PubMed ID: 21224793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmental Versus Partial Portomesenteric Resection in Pancreatectomy for Pancreatic Cancer.
    Baláž P; Gürlich R; Havlůj L; Girsa D; Whitley A; Lawrie K
    J Surg Res; 2023 Aug; 288():233-239. PubMed ID: 37030180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular reconstruction plays an important role in the treatment of pancreatic adenocarcinoma.
    Sgroi MD; Narayan RR; Lane JS; Demirjian A; Kabutey NK; Fujitani RM; Imagawa DK
    J Vasc Surg; 2015 Feb; 61(2):475-80. PubMed ID: 25441672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of superior mesenteric-portal vein resection during pancreatectomy for borderline ductal adenocarcinoma: results of a prospective comparative study.
    Selvaggi F; Mascetta G; Daskalaki D; dal Molin M; Salvia R; Butturini G; Cellini C; Bassi C
    Langenbecks Arch Surg; 2014 Jun; 399(5):659-65. PubMed ID: 24777762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A safe technique for radical antegrade modular pancreatosplenectomy with venous resection for pancreatic cancer.
    Rosso E; Langella S; Addeo P; Nobili C; Oussoultzoglou E; Jaeck D; Bachellier P
    J Am Coll Surg; 2013 Nov; 217(5):e35-9. PubMed ID: 24045139
    [No Abstract]   [Full Text] [Related]  

  • 18. Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcinoma in pancreas.
    Shibata C; Kobari M; Tsuchiya T; Arai K; Anzai R; Takahashi M; Uzuki M; Sawai T; Yamazaki T
    World J Surg; 2001 Aug; 25(8):1002-5. PubMed ID: 11571964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.
    Fuhrman GM; Leach SD; Staley CA; Cusack JC; Charnsangavej C; Cleary KR; El-Naggar AK; Fenoglio CJ; Lee JE; Evans DB
    Ann Surg; 1996 Feb; 223(2):154-62. PubMed ID: 8597509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters.
    Addeo P; Velten M; Averous G; Faitot F; Nguimpi-Tambou M; Nappo G; Felli E; Fuchshuber P; Bachellier P
    Surgery; 2017 Aug; 162(2):264-274. PubMed ID: 28576385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.